Specialty Pharmacy

Further studies needed to evaluate sleep-related risk factors in IBD, authors say.

Thomas Cohn, chief strategy officer at Armada Health Care, discusses the biggest challenges specialty pharmacies will face over the next 5 years.

Researchers found significant improvements in overall survival and in disease-free survival in patients who received trastuzumab in addition to chemotherapy.

Learn about the strains involved in the current and past epidemics, the features of the Ebola virus, information about aerosolized spread, and treatments in development.

Children infected with enterovirus have a 48% increased risk of developing type 1 diabetes.

Researchers identify mechanisms that trigger hematopoietic stem cell production.

Progress in the fight against an Ebola outbreak has been made on 2 fronts.

Treatment inhibits key process that enables cancer cells to multiply.

Notable outbreaks over the past 2 decades have qualified enterovirus D68 as an emerging pathogen.

Chronic inflammation may lead to development of aggressive form of cancer.

Specialty drug spending predicted to grow by more than 16% annually from 2015 to 2018.

Antiretroviral therapy provides similar benefits for stimulant users and non-users alike.

A hospital employee may have been in contact with clinical specimens from a deceased Ebola patient.

The second nurse to become infected with the Ebola virus after treating the index patient in Texas should not have been allowed to board a flight from Ohio earlier this week.

A second health care worker who tested positive for the Ebola virus traveled by air the day before her symptoms appeared.

The disease burden of smoking remains immense despite widespread tobacco cessation efforts.

SVR12 rates significantly higher in patients treated with daclatasvir/peginterferon alfa/ribavirin combination.

Bill Barre, RPh, vice president of business development at MedImpact Healthcare Systems, discusses MedImpact's Centers of Excellence program.

Pharmacy Times and Specialty Pharmacy Times add several new organizations to Strategic Alliance Partnership programs.

Nearly 700 children across 46 states are now infected with the severe respiratory illness.

Palbociclib provides first-line systemic treatment for women with advanced or metastatic breast cancer.

Investigators are working to resolve how a health care worker in Texas contracted the Ebola virus while caring for an infected patient.

Investigational bispecific T-cell engager antibody construct aids immune system in targeting cancer cells.

Diplomat Pharmacy, Inc, the nation's largest independent specialty pharmacy began trading its common stock the NYSE on October 10 in connection with its IPO.

Five US airports that receive the majority of travelers from West African nations will add new layers of entry screening.

In a retrospective study, investigators found that increases in total cholesterol and triglycerides were associated with an increased risk of biochemical recurrence in prostate cancer.

Provides use, cost forecast based on testing, future treatment rates.

The FDA today approved Gilead's Harvoni, the first combination pill to treat chronic hepatitis C virus genotype 1 infection.

The drug combination prevents nausea and vomiting after the start of cancer chemotherapy.